Evaluation of drug-drug interaction between cytochrome P450 substrate Selexipag and Clopidogrel in huma
Not Applicable
Recruiting
- Conditions
- pharmacokinetic trial
- Registration Number
- JPRN-UMIN000032266
- Lead Sponsor
- Hamamatsu University School of Medicine, Clinical Pharmacology and Therapeutics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1 subject who takes medicine 1 week before each 1st and 2nd PK trial 2 subject who has apparent abnormality in advance blood and biochemical examinations 3 subject who were judged to be not eligible in this study by the physician in chrage
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method AUC 0 to 48hrs and 0 to infinity of Selexipag and MRE 269
- Secondary Outcome Measures
Name Time Method